A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: Primary results of the ARISE trial

被引：0

作者：

Ashina, M. ^{[1
,2
]}

Dodick, D. ^{[3
]}

Kudrow, D. ^{[4
]}

Lanteri-Minet, M. ^{[5
,6
]}

Osipova, V.

Palmer, K. ^{[7
]}

Picard, H. ^{[8
]}

Mikol, D. ^{[8
]}

Lenz, R. ^{[8
]}

机构：

[1] Univ Copenhagen, Danish Headache Ctr, Rigshosp Glostrup, Fac Med & Hlth Sci, Copenhagen, Denmark

[2] Univ Copenhagen, Dept Neurol, Rigshosp Glostrup, Fac Med & Hlth Sci, Copenhagen, Denmark

[3] Mayo Clin, Scottsdale, AZ USA

[4] Calif Med Clin Headache, Santa Monica, CA USA

[5] CHU, Pain Dept, Nice, France

[6] CHU, FHU InovPain, Nice, France

[7] Amgen Inc, Cambridge, England

[8] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

PR1045

引用

页码：470 / 470

页数：1

共 50 条

[21] Results of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of astodrimer gel for prevention of recurrent bacterial vaginosis
Schwebke, J.
Carter, B.
Waldbaum, A.
Price, C.
Castellarnau, A.
Paull, J.
McCloud, P.
Kinghorn, G.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (06) : 672 - 673
[22] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
MURPHY, JJ
HEPTINSTALL, S
MITCHELL, JRA
LANCET, 1988, 2 (8604): : 189 - 192
[23] Results of the Open-Label Extension of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
Sun, Hong
Dodick, David W.
Goadsby, Peter
Silberstein, Stephen
Reuters, Uwe
Ashina, Messoud
Saper, Joel R.
Cady, Roger
Zhang, Feng
Trotman, Marie-Louise
Dietrich, Julie
Lenz, Robert
HEADACHE, 2015, 55 : 256 - 257
[24] Efficacy and Safety of Cinnarizine in the Prophylaxis of Migraine in Children: A Double-Blind Placebo-Controlled Randomized Trial
Ashrafi, Mahmoud Reza
Salehi, Soodeh
Malamiri, Reza Azizi
Heidari, Morteza
Hosseini, Seyed Ahmad
Samiei, Mahboubeh
Tavasoli, Ali Reza
Togha, Mansoureh
PEDIATRIC NEUROLOGY, 2014, 51 (04) : 503 - 508
[25] Response to topiramate in the prevention of chronic migraine: results of a double-blind, randomized, placebo-controlled trial
Grazzi, L.
Diener, H-C
Van Oene, J. C.
Lahaye, M.
Schwalen, S.
Goadsby, P. J.
CEPHALALGIA, 2006, 26 (11) : 1368 - 1368
[26] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
Silberstein, Stephen D.
Lipton, Richard B.
Dodick, David W.
Freitag, Frederick G.
Ramadan, Nabih
Mathew, Ninan
Brandes, Jan L.
Bigal, Marcelo
Saper, Joel
Ascher, Steven
Jordan, Donna M.
Greenberg, Steven J.
Hulihan, Joseph
HEADACHE, 2007, 47 (02): : 170 - 180
[27] Topiramate for the prevention of paediatric migraine: a randomized, double-blind, placebo-controlled trial
Winner, P
Pearlman, EM
Linder, S
Jordan, D
Fisher, A
Hulihan, J
CEPHALALGIA, 2004, 24 (09) : 814 - 814
[28] Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial
Winner, P
Pearlman, EM
Linder, SL
Jordan, DM
Fisher, AC
Hulihan, J
HEADACHE, 2005, 45 (10): : 1304 - 1312
[29] Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
Sonbolestan, Seyed Ali
Heshmat, Kiyan
Javanmard, Shaghayegh Haghjooy
Saadatnia, Mohammad
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2013, 4 (01) : 72 - 77
[30] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
Yang, H. K.
Lee, S. H.
Min, K. W.
Park, S. W.
Chung, C. H.
Park, K. S.
Choi, S. H.
Song, K. -H.
Kim, D. -M.
Lee, M. -K.
Sung, Y. A.
Baik, S. H.
Kim, I. J.
Cha, B. -S.
Park, J. H.
Ahn, Y. B.
Lee, I. -K.
Yoo, S. -J.
Kim, J. T.
Park, I. B.
Park, T. S.
Yoon, K. -H.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150

← 1 2 3 4 5 →